BK
Babukumar Kavitha
About Babukumar Kavitha
Data last updated:
Babukumar Kavitha is a Director at G S S Pharma Private Limited (since 2025) and Designated Partner at Medford Pharmaceuticals Llp (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹19.01 Cr; the largest is G S S Pharma Private Limited at ₹14.87 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jan 2025 | 2015 | ₹14.87 Cr (FY 2024) | Active | |
| Designated Partner | 30 Jan 2025 | 2018 | ₹4.13 Cr (FY 2023) | Active |
Board colleagues of Babukumar Kavitha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Geethanjali Chandrareddy | 07170692 | G S S Pharma Private Limited , Medford Pharmaceuticals Llp | Director |
| Kongarahalli Ganga Reddy Nagaraja | 07139302 | G S S Pharma Private Limited , Medford Pharmaceuticals Llp | Director |
| Shivanna Hassan Sridhar | 10861214 | G S S Pharma Private Limited , Medford Pharmaceuticals Llp | Director |
| Vishal Venugopal | 10861148 | G S S Pharma Private Limited | Director |
| Parthasarathy Hari | 10861145 | Medford Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Babukumar Kavitha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babukumar Kavitha
Babukumar Kavitha currently holds 2 directorships: G S S Pharma Private Limited (Director, since 01 Jan 2025, revenue ₹14.87 Cr (FY 2024)); Medford Pharmaceuticals Llp (Designated Partner, since 30 Jan 2025, revenue ₹4.13 Cr (FY 2023)).
Babukumar Kavitha was first appointed on 01 Jan 2025 as Director at G S S Pharma Private Limited.
The 2 current companies of Babukumar Kavitha that report revenue have a combined latest revenue of ₹19.01 Cr: G S S Pharma Private Limited ₹14.87 Cr (FY 2024); Medford Pharmaceuticals Llp ₹4.13 Cr (FY 2023).
The current boards of Babukumar Kavitha's companies include Geethanjali Chandrareddy (G S S Pharma Private Limited), Kongarahalli Ganga Reddy Nagaraja (G S S Pharma Private Limited), Shivanna Hassan Sridhar (G S S Pharma Private Limited), Vishal Venugopal (G S S Pharma Private Limited), Parthasarathy Hari (Medford Pharmaceuticals Llp).